Acetylleucine
(S)-(−)-N-Acetyl-leucine | |
| Names | |
|---|---|
| IUPAC name
2-Acetamido-4-methylpentanoic acid | |
| Other names
N-Acetylleucine; N-Acetyl-L-Leucine | |
| Identifiers | |
| |
3D model (JSmol) |
|
| 1724849 (S)-(−) | |
| ChEBI |
|
| ChEMBL |
|
| ChemSpider | |
| EC Number |
|
| 985259 (S)-(−) | |
| KEGG |
|
| MeSH | acetylleucine |
PubChem CID |
|
| UNII |
|
| |
| |
| Properties | |
| C8H15NO3 | |
| Molar mass | 173.212 g·mol−1 |
| Appearance | White crystals |
| Melting point | −115 to −113 °C; −175 to −172 °F; 158 to 160 K |
| log P | −0.265 |
| Acidity (pKa) | 3.666 |
| Basicity (pKb) | 10.331 |
| Pharmacology | |
| N07CA04 (WHO) | |
| Related compounds | |
Related compounds |
ENU |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Acetylleucine (N-acetyl-leucine) is a modified leucine amino acid.
Two forms are commercialized: N-acetyl-DL-leucine (sold under the brand Tanganil, among others, and used in the treatment of vertigo) and N-acetyl-L-leucine (levacetylleucine, sold under the brand name Aqneursa, and used for the treatment of neurological manifestations of Niemann-Pick disease type C).